🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Qara › Nebraska › Omaha

Qorannoo klinikaalii Dhibee Qara Omaha, NE keessatti

Qorannoo 12 Dhibee Qara f Omaha fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Namoota walitti qabaa jiraSadarkaa 3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Nebraska Medicine-Village Pointe, Omaha
  • fi 3 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Alegent Health Immanuel Medical Center, Omaha
  • Alegent Health Bergan Mercy Medical Center, Omaha
  • Alegent Health Lakeside Hospital, Omaha
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Namoota walitti qabaa jiraSadarkaa 3
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists - Methodist, Omaha
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan, Omaha
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06758401

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Namoota walitti qabaa jiraSadarkaa 2/3
  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07063745

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Research Site, Omaha
Umuriin 18 hanga 95 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05061550

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
  • Nebraska Methodist Hospital, Omaha
  • Heartland Oncology and Hematology LLP, Council Bluffs · Miili 4 fagaatti
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05624996

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nebraska Cancer Specialists, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT04198766

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Nebraska Medical Center, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05242965

Integrated Cancer Repository for Cancer Research

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Methodist Estabrook Cancer Center, Omaha
  • Nebraska Methodist Health System, Omaha
  • University of Nebraska Medical Center, Omaha
  • fi 1 dabalataa
Umuriin 19 hanga 110 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT02012699

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • University of Nebraska Medical Center, Omaha
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT04614103

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nebraska Cancer Specialists, Omaha
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Cam-2026 · NCT06922591

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Omaha
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Dhibee Qara magaalota biroo keessatti

Qorannoo biroo Omaha keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.